Literature DB >> 25215902

Nuclear factor kappa B and cyclo-oxygenase-2: two concordant players in psoriasis pathogenesis.

Ola Ahmed Bakry1, Rehab Monir Samaka, Mohamed Abdel Moneim Shoeib, Sara Mohamed Abdel Aal.   

Abstract

Nuclear factor kappa B (NFκB) is a key regulatory element in a variety of immune and inflammatory pathways, cellular proliferation, differentiation and apoptosis. Cyclo-oxygenase 2 (COX2) is one of the downstream targets of NFκB. The current work aimed to explore the possible role of NFκB and COX2 in psoriasis pathogenesis through their immunohistochemical (IHC) expression in skin biopsies of this disease and correlating this expression with clinico-pathological parameters of studied cases. 103 subjects were studied; including 58 cases with psoriasis vulgaris (lesional and perilesional skin) and 45 normal, age- and gender-matched subjects, as a control group. NFκB and COX2 expressions were evaluated using standard IHC techniques. NFκB and COX2 were upregulated in psoriasis lesional skin compared to perilesional (p < 0.001 for both) and control skin (p < 0.001 for both). Higher NFκB and COX2 H scores were significantly associated with absent granular cell layer (p = 0.02 for both), severe degree of perivascular inflammatory infiltrate (p = 0.03 and 0.002, respectively) and thin suprapapillary epidermis (p = 0.003 and 0.006, respectively). Significant positive correlation was noted between NFκB and COX2 H scores in epidermis (r = 0.41, p = 0.02) and dermis (r = 0.6, p = 0.04) of lesional skin. Significant positive correlation between NFκB H score and PASI score (r = 0.38, p = 0.04) and between COX2 H score and PASI score (r = 0.52, p < 0.001) were detected in lesional epidermis. In conclusion, both NFκB and COX2 play a role in the pathogenesis of chronic plaque psoriasis. This may open an avenue for research for new therapeutic modalities based on their inhibition.

Entities:  

Keywords:  COX2; NFκB; pathogenesis; psoriasis

Mesh:

Substances:

Year:  2014        PMID: 25215902     DOI: 10.3109/01913123.2014.952470

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  7 in total

1.  Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis.

Authors:  Diana Ana-Maria Nițescu; Horia Păunescu; Alina Elena Ștefan; Laurențiu Coman; Corneliu Cristian Georgescu; Andrei Constantin Stoian; Daniela Gologan; Ion Fulga; Oana Andreia Coman
Journal:  Pharmaceutics       Date:  2022-04-18       Impact factor: 6.525

2.  Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice.

Authors:  Yoon-Jae Jeon; Shyam Kishor Sah; Hee Seung Yang; Ji Hae Lee; Jongheon Shin; Tae-Yoon Kim
Journal:  Exp Mol Med       Date:  2017-06-30       Impact factor: 8.718

3.  Defective Induction of COX-2 Expression by Psoriatic Fibroblasts Promotes Pro-inflammatory Activation of Macrophages.

Authors:  Jorge Arasa; María Carmen Terencio; Rosa María Andrés; Asunción Marín-Castejón; Francisca Valcuende-Cavero; Miguel Payá; María Carmen Montesinos
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

4.  Natural product topical therapy in mitigating imiquimod-induced psoriasis-like skin inflammation-underscoring the anti-psoriatic potential of Nimbolide.

Authors:  Nilesh Barku More; Nivya Sharma; Gauthami Pulivendala; Swarna Bale; Chandraiah Godugu
Journal:  Indian J Pharmacol       Date:  2021 Jul-Aug       Impact factor: 1.200

5.  Immunohistochemical Expression of Cyclo-oxygenase 2 and Liver X Receptor-α in Acne Vulgaris.

Authors:  Ola Ahmed Bakry; Shawky Mahmoud El Farargy; Noha Nour El Din El Kady; Hend Farag Abu Dawy
Journal:  J Clin Diagn Res       Date:  2017-09-01

6.  Changes in Proteome of Fibroblasts Isolated from Psoriatic Skin Lesions.

Authors:  Agnieszka Gęgotek; Pedro Domingues; Adam Wroński; Elżbieta Skrzydlewska
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

7.  Epithelial-Macrophage Crosstalk Initiates Sterile Inflammation in Embryonic Skin.

Authors:  Oindrila Bhattacharjee; Uttkarsh Ayyangar; Ambika S Kurbet; Vairavan Lakshmanan; Dasaradhi Palakodeti; Florent Ginhoux; Srikala Raghavan
Journal:  Front Immunol       Date:  2021-10-14       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.